Estrogen receptor antibodies: Specificity and utility in detection, localization and analyses of estrogen receptor α and β

Steroids

Volumn 66, Issue 1, 2001, Pages 1-16

  Pavao, Matthew ^a   Traish, Abdulmaged M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen receptor ; Estrogen receptor ; Monoclonal antibodies; Polyclonal antibodies

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RECEPTOR ANTIBODY;

ANTIBODY SPECIFICITY; HUMAN; IMMUNOCHEMISTRY; NONHUMAN; PHOSPHORYLATION; REVIEW;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; RECEPTORS, ESTROGEN;

EID: 0035238791     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(00)00143-4     Document Type: Review

References (179)

1. Insights from the study of animals lacking functional estrogen receptor
2. The steroid and thyroid hormone receptor superfamily
3. Steroid receptor family; structure and functions
4. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
5. Sequence and expression of human estrogen receptor complementary DNA
6. Human oestrogen receptor cDNA; sequence, expression and homology to v-erb-A
7. The chicken oestrogen receptor sequence; homology with v-erbA and the human oestrogen and glucocorticoid receptors
8. Structural organization and expression of the mouse estrogen receptor
9. Cloning of a novel receptor expressed in rat prostate and ovary
10. ER beta; identification and characterization of a novel human estrogen receptor
11. Cloning and characterization of human estrogen receptor beta isoforms
12. The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro
13. Nuclear receptors enhance our understanding of transcription regulation
14. Gene regulation by steroid hormones
15. Evolution of the nuclear receptor gene superfamily
16. Multiplicity generates diversity in the retinoic acid signalling pathways
17. The nuclear receptor superfamily; the second decade
18. Estrogen-binding substances of target tissues
19. Mechanism of action of the female sex hormones
20. Estrogen receptors in the rat uterus. Relationship between cytoplasmic and nuclear forms of the estrogen binding protein
21. Estrogen receptors in the rat uterus. Multiple forms produced by concentration-dependent aggregation
22. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region
23. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity
24. Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor
25. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor
26. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
27. Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II; consequence on DNA binding
28. Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element
29. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro
30. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
31. Estradiol-binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation
32. Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase
33. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167
34. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex
35. A two-step mechanism for the interaction of estradiol with rat uterus
36. Estrogen receptors in the rat uterus. Studies on the interaction of cytosol and nuclear binding sites
37. Estrogen-independent activation of the receptor protein of calf uterine cytosol
38. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
39. Steroid hormone receptors compete for factors that mediate their enhancer function
40. Estrogen receptor-associated proteins; possible mediators of hormone-induced transcription
41. Estrogen receptors; bioactivities and interactions with cell signaling pathways
42. Nuclear receptor coactivators and corepressors
43. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
44. Sequence requirements for estrogen receptor binding to estrogen response elements
45. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain
46. Structure and specificity of nuclear receptor-coactivator interactions
47. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner)
48. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor
49. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
50. Nuclear receptor coregulators; cellular and molecular biology
51. Nuclear receptor coactivators; multiple enzymes, multiple complexes, multiple functions
52. Estrogen receptor Interaction with co-activators, and co-repressors
53. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II)
54. Targets of activated steroid hormone receptors; basal transcription factors and receptor interacting proteins
55. Tamoxifen activation of the estrogen receptor/AP-1 pathway; potential origin for the cell-specific estrogen-like effects of antiestrogens
56. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites
57. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells
58. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression
59. Functional synergy between the transcription factor Sp1 and the estrogen receptor
60. Functional domains of the human estrogen receptor
61. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins
62. Activators and targets
63. Structure(?) and function of acidic transcription activators
64. Transcriptional activation; a complex puzzle with few easy pieces
65. Something old, some things new; the steroid receptor superfamily in Drosophila
66. The human estrogen receptor has two independent nonacidic transcriptional activation functions
67. The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific
68. Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor
69. Distinct classes of transcriptional activating domains function by different mechanisms
70. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells
71. Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor
72. Solution structure of the DNA-binding domain of the oestrogen receptor
73. Anatomy of the steroid receptor zinc finger region
74. Signal transduction by steroid hormones; nuclear localization is differentially regulated in estrogen and glucocorticoid receptors
75. The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator
76. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen
77. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
78. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor; presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity
79. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
80. Molecular basis of agonism and antagonism in the oestrogen receptor
81. Identification of two transactivation domains in the mouse oestrogen receptor
82. Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis
83. Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast
84. The carboxy-terminal F domain of the human estrogen receptor; role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists
85. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern
86. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta
87. Molecular cloning and characterization of Japanese eel estrogen receptor cDNA
88. Partial cloning and distribution of estrogen receptor beta in the avian brain
89. Oestrogen receptors-an overview
90. Molecular cloning and characterization of human estrogen receptor betacx; a potential inhibitor ofestrogen action in human
91. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues
92. A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action
93. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer
94. Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor, α-beta heterodimeric complex
95. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1
96. The estrogen receptor β-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
97. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells
98. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
99. The novel estrogen receptor-β subtype; potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens
100. The estrogen receptor beta subtype; a novel mediator of estrogen action in neuroendocrine systems
101. Differential distribution and regulation of estrogen receptor-α and-β mRNA within the female rat brain
102. Estrogen receptor beta-a new dimension in estrogen mechanism of action
103. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta
104. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha
105. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha
106. Specific nuclear triiodothyronine binding sites in rat liver and kidney
107. Antibodies to estrogen receptor; immunochemical similarity of estrophilin from various mammalian species
108. Monoclonal antibodies to estrophilin; probes for the study of estrogen receptors
109. Monoclonal antibodies to human estrogen receptor
110. Immunochemical studies of estrogen receptors
111. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells
112. An immunocytochemical method for demonstrating estrogen receptor in human uterus using monoclonal antibodies to human estrophilin
113. Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle
114. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors
115. Immunoelectron microscopic localization of estrogen receptor with monoclonal estrophilin antibodies
116. The use of monoclonal antibodies to estrogen receptors (ER) for immunoperoxidase detection of ER in paraffin sections of human breast cancer tissue
117. Structure and dynamics of the estrogen receptor
118. Monoclonal antibodies against estrogen receptor; interaction with different molecular forms and functions of the receptor
119. Characterization of polyclonal antibodies to preselected domains of the human estrogen receptor
120. Development and characterization of monoclonal antibodies to a specific domain of human estrogen receptor
121. Binding of site-directed monoclonal antibodies to an epitope located in the A/B region (amino acids 140-154) of human estrogen receptor-induced conformational changes in an epitope in the DNA-binding domain
122. Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen receptor-negative human breast cancer
123. Antisera to a synthetic peptide recognize native and denatured rat estrogen receptors
124. Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor
125. Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER)
126. Transcription and translation of estrogen receptor-β in the male reproductive tract of estrogen receptor-α knock-out and wild-type mice
127. Demonstration of estrogen receptor-β immunoreactivity in human growth plate cartilage
128. Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent
129. Characterization of estrogen receptor-β (ERbeta) messenger ribonucleic acid and protein expression in rat granulosa cells
130. Differential colocalization of estrogen receptor beta (ERbeta) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain; an immunocytochemical study
131. Differential expression of estrogen receptor-β and estrogen receptor-α in the rat ovary
132. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer
133. Site-directed polyclonal antibodies inhibit binding of activated estrogen receptor to DNA
134. Identification of structurally altered estrogen receptors in human breast cancer by site-directed monoclonal antibodies
135. Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell
136. Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro
137. hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in vitro
138. Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression
139. Determination of estrogen receptor in primary breast cancer using two different monoclonal antibodies, and correlation with its mRNA expression
140. Characterization of an antiidiotypic antibody mimicking the actions of estradiol and its interaction with estrogen receptors
141. Ontogenetic changes in the expression of estrogen receptor alpha and beta in rat pituitary gland detected by immunohistochemistry
142. The production of antibodies against the conserved cysteine region of steroid receptors and their use in characterizing the avian progesterone receptor
143. Antibodies to chicken progesterone receptor peptide 523-536 recognize a site exposed in receptor-deoxyribonucleic acid complexes but not in receptor-heat shock protein-90 complexes
144. Monoclonal and polyclonal antibodies to human progesterone receptor peptide-(533-547) recognize a specific site in unactivated (8S) and activated (4S) progesterone receptor and distinguish between intact and proteolyzed receptors
145. Role of estrogen receptor ligand and estrogen response element sequenceon interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF)
146. Monoclonal antibody recognition of multiple forms of estrogen receptor tagged with [125I]methoxy-iodovinyl estradiol in ovarian carcinomas
147. Structural analysis of covalently labeled estrogen receptors by limited proteolysis and monoclonal antibody reactivity
148. A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain
149. Immunodetection of estrogen receptors in fetal and neonatal male mouse reproductive tracts
150. Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays
151. Immunocytochemical demonstration of estrogen receptors by monoclonal antibodies in human breast cancer; correlation with estrogen receptor assay by dextran-coated charcoal method
152. Estrogen receptors alpha and beta in the rodent mammary gland
153. Steroid hormone receptors and their regulation by phosphorylation
154. Current status of estrogen and progesterone receptors in breast cancer
155. Hormone dependency of breast cancer
156. Human breast cancer; heterogeneity of estrogen binding sites
157. Oestrogen receptor assay-limitation of the method
158. Estrogen receptor content and ploidy of human mammary carcinoma
159. Estrogen receptor functional status in human breast cancer
160. Estrogen receptor-β messenger RNA expression in human breast tumor biopsies; relationship to steroid receptor status and regulation by progestins
161. Coexpression of estrogen receptor alpha and beta; poor prognostic factors in human breast cancer?
162. Subunit composition of the molybdate-stabilized '8-9 S' nontransformed estradiol receptor purified from calf uterus
163. Oligomeric structures of cytosoluble estrogen-receptor complexes as studied by anti-estrogen receptor antibodies and chemical crosslinking of intact cells
164. Transcriptional regulation by a naturally occurring truncated rat estrogen receptor (ER), truncated ER product-1 (TERP-1)
165. Estrogen receptor binding to DNA; affinity for nonpalindromic elements from the rat prolactin gene
166. Estrogen receptor domains E and F; role in dimerization and interaction with coactivator RIP-140
167. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines
168. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor
169. Estrogen receptor (alpha and beta) expression in the excurrent ducts of the adult male rat reproductive tract
170. Estrogen receptor immunoreactivity in rat brain; rapid effects of estradiol injection
171. Effect of estradiol on estrogen receptor expression in rat uterine cell types
172. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding
173. Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry